Ovarian Function Suppression in Premenopausal Women With Concurrent Endocrine Therapy Use.

Fleege, Nicole M Grogan; Li, Yajing; Kidwell, Kelley M; Henry, N Lynn

Fleege, Nicole M Grogan; Li, Yajing; Kidwell, Kelley M; Henry, N Lynn.

Afiliação

Fleege NMG; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI; Division of Hematology/Oncology, Department of Internal Medicine, University of Iowa Hospitals and Clinics, Iowa City, IA. Electronic address: Nicole-fleege@uiowa.edu.
Li Y; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN.
Kidwell KM; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, MI.
Henry NL; Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI.

Clin Breast Cancer ; 23(4): 454-460, 2023 06.

Article em En | MEDLINE | ID: mdl-37076363

Assuntos

Neoplasias da Mama; Feminino; Humanos; Neoplasias da Mama/terapia; Antineoplásicos Hormonais/efeitos adversos; Estudos Retrospectivos; Ovário; Estradiol; Quimioterapia Adjuvante; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Pré-Menopausa; Tamoxifeno/uso terapêutico

Palavras-chave

Adjuvant endocrine therapy; Breast cancer; Clinical research; Estrogen-receptor-positive breast cancer; Ovarian function suppression

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Tipo de estudo: Guideline / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Revista: Clin Breast Cancer Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google